Literature DB >> 22018426

Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.

Alyson Kaye1.   

Abstract

Toxoplasmosis is a rare disease caused by the obligate intracellular protozoan parasite, Toxoplasma gondii. Most persons with toxoplasmosis in the United States are asymptomatic, but if a woman is infected during pregnancy, the parasite can cross the placenta and cause congenital toxoplasmosis in the fetus. The severity of congenital toxoplasmosis depends on when in the pregnancy the mother is exposed, but it can cause ocular and central nervous system disease as well as lead to growth failure and hearing and vision abnormalities. Congenital toxoplasmosis is treated with a combination of pyrimethamine, sulfadiazine, and leucovorin. It is important for pediatric nurse practitioners to be aware of the clinical presentation and treatment of congenital toxoplasmosis.
Copyright © 2011 National Association of Pediatric Nurse Practitioners. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22018426     DOI: 10.1016/j.pedhc.2010.04.008

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  23 in total

1.  Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.

Authors:  Anthony P Sinai; Elizabeth A Watts; Animesh Dhara; Robert D Murphy; Matthew S Gentry; Abhijit Patwardhan
Journal:  Curr Clin Microbiol Rep       Date:  2016-10-04

2.  PopNet: A Markov Clustering Approach to Study Population Genetic Structure.

Authors:  Javi Zhang; Asis Khan; Andrea Kennard; Michael E Grigg; John Parkinson
Journal:  Mol Biol Evol       Date:  2017-07-01       Impact factor: 16.240

3.  Unexpected Diagnosis of Cerebral Toxoplasmosis by 16S and D2 Large-Subunit Ribosomal DNA PCR and Sequencing.

Authors:  Alexandra Y C Kruse; Lasse Kvich; Steffen Eickhardt; Lars H Omland; Thomas Bjarnsholt; Claus Moser
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

4.  Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns.

Authors:  Jean-Benjamin Murat; Céline Dard; Hélène Fricker Hidalgo; Marie-Laure Dardé; Marie-Pierre Brenier-Pinchart; Hervé Pelloux
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

5.  Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.

Authors:  Afonso P Basto; Joachim Müller; Riccardo Rubbiani; David Stibal; Federico Giannini; Georg Süss-Fink; Vreni Balmer; Andrew Hemphill; Gilles Gasser; Julien Furrer
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

6.  Food Safety Instruction Improves Knowledge and Behavior Risk and Protection Factors for Foodborne Illnesses in Pregnant Populations.

Authors:  Patricia Kendall; Robert Scharff; Susan Baker; Jeffrey LeJeune; John Sofos; Lydia Medeiros
Journal:  Matern Child Health J       Date:  2017-08

7.  Toxoplasma gondii seroprevalence in Mali.

Authors:  Dinkorma T Ouologuem; Abdoulaye A Djimdé; Nouhoum Diallo; Ogobara K Doumbo; David S Roos
Journal:  J Parasitol       Date:  2012-08-27       Impact factor: 1.276

8.  Mesial Temporal Lobe Epilepsy in Congenital Toxoplasmosis: A Case Report.

Authors:  Woo Kyo Jeong; Byung-Euk Joo; Ji-Hye Seo; Jun Kyu Mun; Juhyeon Kim; Dae-Won Seo
Journal:  J Epilepsy Res       Date:  2015-06-30

9.  Seroepidemiological analysis of toxoplasmosis in college students.

Authors:  Jaqueline Polizeli Rodrigues; Fernando Frei; Italmar Teodorico Navarro; Luciana Pereira Silva; Monica Yonashiro Marcelino; Heitor Franco de Andrade-Junior; Carolina Arruda de Faria; Marislene Santos; João Tadeu Ribeiro-Paes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-01-05

10.  Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFNγ-induced STAT1 transcriptional activity.

Authors:  Anne G Schneider; Delbert S Abi Abdallah; Barbara A Butcher; Eric Y Denkers
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.